Published in N Engl J Med on August 20, 1970
A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety. Clin J Am Soc Nephrol (2012) 1.75
Pseudorejection: factors mimicking rejection in renal allograft recipients. Ann Surg (1977) 1.13
Renal transplantation in infants and children. Ann Surg (1971) 1.04
Factors in the differential rate of arteriosclerosis (AS) between long surviving renal transplant recipients and dialysis patients. Ann Surg (1976) 0.96
Quality of life is improved and kidney function preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrate. J Pediatr (2014) 0.92
The history of cystinosis: lessons for clinical management. Int J Nephrol (2011) 0.86
Cystinosis as a lysosomal storage disease with multiple mutant alleles: Phenotypic-genotypic correlations. World J Nephrol (2013) 0.79
Natural history of adolescent-onset cystinosis. Pediatr Nephrol (2011) 0.77
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med (1980) 9.64
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Clinical, microbiologic, neurologic and pathologic features. Am J Med (1967) 4.08
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet (1979) 4.01
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
Changes in blood coagulation. Arch Surg (1966) 3.22
Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis (1990) 3.04
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
Factors influencing endothelial cell proliferation in vitro. J Cell Physiol (1978) 2.99
The immune complex glomerulonephritis of bacterial endocarditis. Medicine (Baltimore) (1972) 2.82
Studies of blood flow and ultrastructural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery (1968) 2.58
Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. J Clin Invest (1981) 2.50
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood (1977) 2.36
Role of marrow-derived monocytes and mesangial cells in removal of immune complexes from renal glomeruli. J Exp Med (1979) 2.27
SEROTYPING FOR HOMOTRANSPLANTATION. VII. SELECTION OF KIDNEY DONORS FOR THIRTY-TWO RECIPIENTS. Ann N Y Acad Sci (1966) 2.25
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23
Structural-functional correlations in renal disease. II. The correlations. Hum Pathol (1970) 2.18
Glomerular cell culture. Lab Invest (1985) 2.16
Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab Invest (1983) 2.08
Human renal transplants. I. Glomerular changes. Lab Invest (1967) 2.06
The glomerular deposition of soluble immune complexes prepared with reduced and alkylated antibodies and with intact antibodies in mice. Lab Invest (1976) 2.01
Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J Pediatr (1998) 1.99
Escherichia coli O157:H7 as the predominant pathogen associated with the hemolytic uremic syndrome: a prospective study in the Pacific Northwest. Pediatrics (1987) 1.98
Cloning and sequence of cDNA coding for alpha 1-antitrypsin. Proc Natl Acad Sci U S A (1981) 1.91
Avenues of future research in homotransplantation of the liver with particular reference to hepatic supportive procedures, antilymphocyte serum, and tissue typing. Am J Surg (1966) 1.89
Progress in homotransplantation of the liver. Adv Surg (1966) 1.83
Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82
Serotyping for homotransplantation. V. Evaluation of a matching scheme. Transplantation (1966) 1.78
The composition of glomerulosclerosis. I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab Invest (1984) 1.72
Homotransplantation of the liver. Transplantation (1967) 1.71
Human glomerular cells in vitro: isolation and characterization. Transplant Proc (1980) 1.69
Auxiliary liver transplantation: effect of host portacaval shunt. Experimental and clinical observations. Arch Surg (1966) 1.66
Hyperlipidaemia after successful renal transplantation. Lancet (1974) 1.64
Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res (1980) 1.63
Hickman catheter infections in patients with malignancies. Medicine (Baltimore) (1984) 1.61
Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci U S A (1992) 1.58
Asymptomatic inferior vena cava abnormalities in three children with end-stage renal disease: risk factors and screening guidelines for pretransplant diagnosis. Pediatr Transplant (2000) 1.58
Hemophilia: role of organ homografts. Science (1969) 1.56
Surgically correctable intra-abdominal complications before and after renal homotransplantation. Ann Surg (1968) 1.56
Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. Am J Pathol (1988) 1.55
Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci U S A (1994) 1.54
The effect of partial portacaval transposition on the canine liver. Surgery (1967) 1.54
Effect of cationized antibodies in performed immune complexes on deposition and persistence in renal glomeruli. J Exp Med (1982) 1.54
The disappearance kinetics and glomerular deposition of small-latticed soluble immune complexes. Immunology (1982) 1.54
Granular pneumocytes in primary culture secrete several major components of the extracellular matrix. Biochemistry (1983) 1.47
Removal of glomerular deposits of immune complexes in mice by administration of excess antigen. Lab Invest (1980) 1.42
LIGHT AND ELECTRON MICROSCOPIC STUDY OF BIOPSIES FROM THIRTY-THREE HUMAN RENAL ALLOGRAFTS AND AN ISOGRAFT 134-212 YEARS AFTER TRANSPLANTATION. Ann N Y Acad Sci (1996) 1.42
Nephrotoxin exposure in utero reduces glomerular number in sclerosis-prone but not sclerosis-resistant mice. Kidney Int (1999) 1.40
Use of the Hickman-Crawford critical care catheter in marrow transplant recipients: a pulmonary artery catheter-adaptable central venous access. Crit Care Med (1994) 1.39
Late function of the orthotopic liver homograft. Surg Forum (1965) 1.36
Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man. Nature (1982) 1.35
The specific influence of nonhepatic splanchnic venous blood flow on the liver. Surg Forum (1965) 1.34
Glomerulosclerosis is transmitted by bone marrow-derived mesangial cell progenitors. J Clin Invest (2001) 1.32
Glomerular epithelial, mesangial, and endothelial cell lines from transgenic mice. Kidney Int (1988) 1.32
The increasing incidence of the hemolytic-uremic syndrome in King County, Washington: lack of evidence for ascertainment bias. Am J Epidemiol (1989) 1.31
Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J Am Soc Nephrol (2001) 1.30
Evaluating the child with short stature. Pediatr Clin North Am (1987) 1.28
Dissociation of glomerular hypertrophy, cell proliferation, and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. J Clin Invest (1996) 1.23
Blood coagulation in uremic patients before and after hemodialysis and transplantation of the kidney. Arch Surg (1966) 1.22
Effects of lipopolysaccharide on human endothelial cells in culture. Thromb Res (1983) 1.22
Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice. J Biol Chem (2001) 1.21
Glomerular lesions in nonobese diabetic mouse: before and after the onset of hyperglycemia. Lab Invest (1990) 1.20
Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone. Lab Invest (1991) 1.20
Extracellular matrix in normal and fibrotic human lungs. Am Rev Respir Dis (1985) 1.19
Human glomerular visceral epithelial cells synthesize a basal lamina collagen in vitro. Proc Natl Acad Sci U S A (1979) 1.19
Hemolytic-uremic syndrome and myocarditis. Association with coxsackievirus B infection. Am J Dis Child (1971) 1.19
Studies of progressive glomerular sclerosis in the rat. Am J Pathol (1986) 1.18
Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol (1990) 1.17
Mesangial cells, effect of monocyte products on proliferation and matrix synthesis. Transplant Proc (1982) 1.15
Age-related changes in alpha 1- and alpha 2-chain type IV collagen mRNAs in adult mouse glomeruli: competitive PCR. Am J Physiol (1992) 1.14
Strain differences rather than hyperglycemia determine the severity of glomerulosclerosis in mice. Kidney Int (1998) 1.13
Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice. Am J Pathol (1999) 1.12
Large glomerular size in Pima Indians: lack of change with diabetic nephropathy. J Am Soc Nephrol (1992) 1.11
Mesangial cell turnover: effect of heparin and peptide growth factors. Lab Invest (1991) 1.11
Familial pancreatitis. Am J Surg (1968) 1.11
Gender-specific effects of endogenous testosterone: female alpha-estrogen receptor-deficient C57Bl/6J mice develop glomerulosclerosis. Kidney Int (2007) 1.11
Combined AGE inhibition and ACEi decreases the progression of established diabetic nephropathy in B6 db/db mice. Kidney Int (2006) 1.10
Glomerulosclerosis and renal cysts in mice transgenic for the early region of SV40. Kidney Int (1987) 1.10
Home hemodialysis: six years' experience. N Engl J Med (1970) 1.09
Ultrastructure of human renal obsolescent glomeruli. Lab Invest (1969) 1.09
Hemolytic uremic syndrome epidemiology: a population-based study in King County, Washington, 1971 to 1980. Pediatrics (1987) 1.09
Attempted spleen transplant in classical hemophilia. Transplantation (1969) 1.09
Glomerulosclerosis in mice transgenic for growth hormone. Increased mesangial extracellular matrix is correlated with kidney mRNA levels. J Exp Med (1991) 1.09
The clinical use of antilymphocyte globulin in renal homotransplantation. Transplantation (1967) 1.09
Safety and efficacy of erythropoietin in children with chronic renal failure. Pediatr Nephrol (1999) 1.08
Chronic renal homograft function: correlation with histology and lymphocyte antigen matching. Am J Med (1967) 1.08
Studies on binding and mitogenic effect of insulin and insulin-like growth factor I in glomerular mesangial cells. Endocrinology (1988) 1.07
Short communication immune mechanisms in human recipients of renal allografts. Cell Immunol (1970) 1.07
IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy. Diabetes (1999) 1.07
Colistimethate toxicity. Report of a fatal case in a previously healthy child. JAMA (1969) 1.06
Calculi in a Meckel's diverticulum--a cause of chronic anemia. Gastroenterology (1972) 1.06
Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis. Am J Pathol (2001) 1.05
The contribution of glomerular mesangial cells to progressive glomerulosclerosis. Semin Nephrol (1989) 1.05
Organ homografts for hemophilia. Transplant Proc (1969) 1.03
Glomerular localization of preformed immune complexes prepared with anionic antibodies or with cationic antigens. Lab Invest (1984) 1.03
Structural-functional correlations in renal disease. I. A method for assaying and classifying histopathologic changes in renal disease. Hum Pathol (1970) 1.03